New advice on modified-release morphine

The Royal Pharmaceutical Society has reviewed its position on brand-name prescribing of modified-release morphine preparations and fentanyl patches.

The society’s practice committee decided there was no compelling evidence to show that pain control was affected by switching between brands of modified-release morphine preparations with the same release profile. 

There was also no evidence of a difference in the rate of delivery between brands of fentanyl patches when used in accordance with the product licence, says the society. 

As a result, the practice committee does not recommend routine brand name prescribing of modified-release morphine preparations and fentanyl patches. 

The committee warned that pharmacists should aim to prevent unintentional changes of the brand supplied to patients. If the brand of strong modified-release morphine preparations needs to be changed, then the pharmacist should ensure that the patient and the patient’s carers understand and accept the need for change. 

Pharmacists were also reminded: ‘There are important differences between matrix patches and reservoir patches. Reservoir patches of fentanyl should never be cut to deliver a smaller dose because this disrupts the controlled-release mechanism.’

For general enquiries contact the society’s practice and quality improvement directorate at practice@rpsgb.org.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Medical examiners to scrutinise deaths in community settings

The MDU's Dr Kathryn Leask explains how the expansion of the medical examiner system...

Person receiving a COVID-19 booster

COVID-19 booster campaign to start on 5 September, NHS England says

The COVID-19 booster programme will begin in care homes and for housebound patients...

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...